Advancing Geroscience Research and Translation

By applying venture philanthropy principles to fund high-risk, high-reward research, we accelerate breakthrough therapies, because strategic, flexible investment can de-risk early-stage science and attract further capital. This strategy involves treating philanthropic funding like venture capital—targeting innovative, early-stage research with high transformative potential, often in environments where traditional funders hesitate to invest. It distinguishes itself from conventional grantmaking by emphasizing financial discipline, reinvestment of returns, and active management akin to venture capital, as seen in both EB Research Partnership and the Alzheimer’s Drug Discovery Foundation.

By delivering integrated, person-centered support services in home and community settings, older adults maintain independence and avoid institutionalization, because addressing medical, social, and emotional needs in familiar environments preserves dignity, continuity, and well-being. This strategy centers on enabling seniors to remain in their homes and communities as they age, through coordinated care that includes health management, social support, and environmental adaptation. It distinguishes itself from institutional or facility-based models by prioritizing autonomy, individual choice, and holistic need fulfillment within the context of existing social and physical environments. While specific tactics vary—from geriatric care management to home-based rehabilitation—the shared theory is that independence and quality of life are best sustained when care is brought to the person, not the other way around.

By providing respite, financial relief, and holistic support to caregivers, we sustain caregiving capacity and improve care recipient outcomes, because caregiver well-being is foundational to the stability, quality, and continuity of care. This strategy centers on the interdependence between caregiver resilience and long-term care effectiveness, particularly for individuals with developmental disabilities, dementia, or aging-related needs. Unlike direct service models that focus solely on the care recipient, this approach explicitly treats caregiver support as a lever for systemic stability—addressing burnout, isolation, and practical burdens through respite care, peer networks, financial aid, and tailored resources. What distinguishes it is its causal theory: that supporting the caregiver is not ancillary but central to achieving sustainable, high-quality outcomes for those they care for.

By creating shared research resources, infrastructure, and open collaboration platforms, we accelerate scientific discovery and translation, because removing barriers to access, reducing duplication, and fostering interdisciplinary exchange enable faster, more efficient progress than isolated efforts can achieve. This strategy centers on building centralized, open-access assets—such as biorepositories, data sets, biofoundries, conferencing forums, and physical research facilities—that lower entry barriers and align global researchers around common goals. Unlike traditional models that rely on individual lab autonomy or proprietary control, this approach treats knowledge and tools as public goods, enabling cumulative, coordinated advancement across fragmented fields like rare disease and aging research. It is distinguished by its emphasis on systemic resource-sharing rather than isolated funding or education initiatives.

By convening cross-sector partners around shared goals and aligned resources, we produce systemic change, because coordinated action across institutions amplifies impact beyond what any single organization can achieve. This strategy centers on uniting diverse stakeholders—nonprofits, government, private sector, and communities—through structured collaboration to address complex social problems. It distinguishes itself from individualized or siloed interventions by emphasizing shared agendas, measurable outcomes, and sustained coordination. While some variants emphasize data, equity, or fiscal alignment, the core theory of change is that collective, aligned effort generates transformational scale and sustainability.

By delivering integrated health and support services directly in patients’ homes, we improve health outcomes and preserve independence, because care in a familiar, non-institutional environment enhances comfort, adherence, and personalization while reducing fragmentation and institutional reliance. This strategy centers on reorienting care delivery from clinical or institutional settings to the patient’s home, not merely as a logistical choice but as a therapeutic one. It assumes that the home environment enables more holistic, coordinated, and dignified care by allowing providers to observe and respond to real-world living conditions, support autonomy, and integrate medical, social, and functional needs. Unlike facility-based models or general outreach programs, this approach treats the home as a clinically meaningful site of care planning and intervention.

By combining research, advocacy, communications, organizing, and other tactics across multiple domains, organizations produce systemic change because sustained impact requires coordinated pressure on cultural, political, institutional, and public opinion fronts. This strategy involves intentionally aligning diverse tools—such as litigation, storytelling, grassroots mobilization, policy advocacy, and cultural expression—not as isolated tactics but as mutually reinforcing components of a unified theory of change. What distinguishes it from narrower approaches is its insistence on integration across levers of power (e.g., courts, media, communities) to create synergistic impact, rather than relying on any single method. While some organizations emphasize research or narrative or organizing alone, this cluster reflects a shared belief that durable reform emerges only when multiple pathways to change are activated simultaneously.

By fostering deep personal and professional relationships across borders through immersive exchange and dialogue, we strengthen bilateral cooperation and drive transnational change, because trust built through lived experience and sustained engagement enables collaboration that endures political shifts and institutional barriers. This strategy centers on the belief that durable international cooperation emerges not just from policy alignment or knowledge transfer, but from the cultivation of mutual understanding through direct human connection. It distinguishes itself from purely informational or advocacy-based approaches by prioritizing relationship-building as the primary mechanism for change—leveraging cohort models, cross-sector dialogues, alumni networks, and shared cultural practices to create resilient transnational communities. Unlike one-off exchanges or top-down diplomacy, this approach invests in long-term network formation where trust, shared values, and personal commitmen

By aligning patient education, community mobilization, and stakeholder collaboration with targeted research initiatives, accelerate therapeutic development and improve patient outcomes, because integrated ecosystems of knowledge, funding, and lived experience reduce duplication, prioritize patient-centered science, and sustain momentum in rare disease research. This strategy combines awareness, education, and grassroots engagement with direct research funding and infrastructure—such as biorepositories, patient registries, and collaborative science platforms—to create a self-reinforcing cycle where informed communities drive research relevance and urgency. Unlike standalone education or research funding efforts, this approach ensures that scientific progress is continuously informed by patient needs and real-world data, while advocacy gains credibility through scientific rigor. It is distinct in its bidirectional flow between community and lab, making it a cornerstone strategy across r